Megna Michael R bought KNSA
August 4, 2025 · Form 4 insider transaction
Megna Michael R bought 17,000 shares of Kiniksa Pharmaceuticals International, plc at $15.52 per share, a transaction worth $263.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,000
Price
$15.52
Total value
$263.8K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateAugust 4, 2025
Filing dateAugust 6, 2025
Shares owned after50,041
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.